Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
Abstract The collagen- and calcium-binding EGF domains 1 (CCBE1) protein is necessary for lymphangiogenesis. Its C-terminal collagen-like domain was shown to be required for the activation of the major lymphangiogenic growth factor VEGF-C (Vascular Endothelial Growth Factor-C) along with the ADAMTS3...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d11b857cbde0493591e19aca144a0242 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d11b857cbde0493591e19aca144a0242 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d11b857cbde0493591e19aca144a02422021-12-02T15:06:18ZEfficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE110.1038/s41598-017-04982-12045-2322https://doaj.org/article/d11b857cbde0493591e19aca144a02422017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04982-1https://doaj.org/toc/2045-2322Abstract The collagen- and calcium-binding EGF domains 1 (CCBE1) protein is necessary for lymphangiogenesis. Its C-terminal collagen-like domain was shown to be required for the activation of the major lymphangiogenic growth factor VEGF-C (Vascular Endothelial Growth Factor-C) along with the ADAMTS3 (A Disintegrin And Metalloproteinase with Thrombospondin Motifs-3) protease. However, it remained unclear how the N-terminal domain of CCBE1 contributed to lymphangiogenic signaling. Here, we show that efficient activation of VEGF-C requires its C-terminal domain both in vitro and in a transgenic mouse model. The N-terminal EGF-like domain of CCBE1 increased VEGFR-3 signaling by colocalizing pro-VEGF-C with its activating protease to the lymphatic endothelial cell surface. When the ADAMTS3 amounts were limited, proteolytic activation of pro-VEGF-C was supported by the N-terminal domain of CCBE1, but not by its C-terminal domain. A single amino acid substitution in ADAMTS3, identified from a lymphedema patient, was associated with abnormal CCBE1 localization. These results show that CCBE1 promotes VEGFR-3 signaling and lymphangiogenesis by different mechanisms, which are mediated independently by the two domains of CCBE1: by enhancing the cleavage activity of ADAMTS3 and by facilitating the colocalization of VEGF-C and ADAMTS3. These new insights should be valuable in developing new strategies to therapeutically target VEGF-C/VEGFR-3-induced lymphangiogenesis.Sawan Kumar JhaKhushbu RauniyarTerhi KarpanenVeli-Matti LeppänenPascal BrouillardMiikka VikkulaKari AlitaloMichael JeltschNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Sawan Kumar Jha Khushbu Rauniyar Terhi Karpanen Veli-Matti Leppänen Pascal Brouillard Miikka Vikkula Kari Alitalo Michael Jeltsch Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 |
description |
Abstract The collagen- and calcium-binding EGF domains 1 (CCBE1) protein is necessary for lymphangiogenesis. Its C-terminal collagen-like domain was shown to be required for the activation of the major lymphangiogenic growth factor VEGF-C (Vascular Endothelial Growth Factor-C) along with the ADAMTS3 (A Disintegrin And Metalloproteinase with Thrombospondin Motifs-3) protease. However, it remained unclear how the N-terminal domain of CCBE1 contributed to lymphangiogenic signaling. Here, we show that efficient activation of VEGF-C requires its C-terminal domain both in vitro and in a transgenic mouse model. The N-terminal EGF-like domain of CCBE1 increased VEGFR-3 signaling by colocalizing pro-VEGF-C with its activating protease to the lymphatic endothelial cell surface. When the ADAMTS3 amounts were limited, proteolytic activation of pro-VEGF-C was supported by the N-terminal domain of CCBE1, but not by its C-terminal domain. A single amino acid substitution in ADAMTS3, identified from a lymphedema patient, was associated with abnormal CCBE1 localization. These results show that CCBE1 promotes VEGFR-3 signaling and lymphangiogenesis by different mechanisms, which are mediated independently by the two domains of CCBE1: by enhancing the cleavage activity of ADAMTS3 and by facilitating the colocalization of VEGF-C and ADAMTS3. These new insights should be valuable in developing new strategies to therapeutically target VEGF-C/VEGFR-3-induced lymphangiogenesis. |
format |
article |
author |
Sawan Kumar Jha Khushbu Rauniyar Terhi Karpanen Veli-Matti Leppänen Pascal Brouillard Miikka Vikkula Kari Alitalo Michael Jeltsch |
author_facet |
Sawan Kumar Jha Khushbu Rauniyar Terhi Karpanen Veli-Matti Leppänen Pascal Brouillard Miikka Vikkula Kari Alitalo Michael Jeltsch |
author_sort |
Sawan Kumar Jha |
title |
Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 |
title_short |
Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 |
title_full |
Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 |
title_fullStr |
Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 |
title_full_unstemmed |
Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 |
title_sort |
efficient activation of the lymphangiogenic growth factor vegf-c requires the c-terminal domain of vegf-c and the n-terminal domain of ccbe1 |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/d11b857cbde0493591e19aca144a0242 |
work_keys_str_mv |
AT sawankumarjha efficientactivationofthelymphangiogenicgrowthfactorvegfcrequiresthecterminaldomainofvegfcandthenterminaldomainofccbe1 AT khushburauniyar efficientactivationofthelymphangiogenicgrowthfactorvegfcrequiresthecterminaldomainofvegfcandthenterminaldomainofccbe1 AT terhikarpanen efficientactivationofthelymphangiogenicgrowthfactorvegfcrequiresthecterminaldomainofvegfcandthenterminaldomainofccbe1 AT velimattileppanen efficientactivationofthelymphangiogenicgrowthfactorvegfcrequiresthecterminaldomainofvegfcandthenterminaldomainofccbe1 AT pascalbrouillard efficientactivationofthelymphangiogenicgrowthfactorvegfcrequiresthecterminaldomainofvegfcandthenterminaldomainofccbe1 AT miikkavikkula efficientactivationofthelymphangiogenicgrowthfactorvegfcrequiresthecterminaldomainofvegfcandthenterminaldomainofccbe1 AT karialitalo efficientactivationofthelymphangiogenicgrowthfactorvegfcrequiresthecterminaldomainofvegfcandthenterminaldomainofccbe1 AT michaeljeltsch efficientactivationofthelymphangiogenicgrowthfactorvegfcrequiresthecterminaldomainofvegfcandthenterminaldomainofccbe1 |
_version_ |
1718388543091376128 |